Targeting H3K36 methyltransferases NSDs: a promising strategy for tumor targeted therapy

Signal Transduct Target Ther. 2021 Jun 3;6(1):220. doi: 10.1038/s41392-021-00616-1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinogenesis / genetics
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / pathology
  • Cell Line, Tumor
  • Heterografts
  • Histone-Lysine N-Methyltransferase / genetics*
  • Humans
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / pathology
  • Mice
  • Nuclear Proteins / genetics*
  • Receptor, Fibroblast Growth Factor, Type 1 / genetics
  • Repressor Proteins / genetics*

Substances

  • Nuclear Proteins
  • Repressor Proteins
  • Histone-Lysine N-Methyltransferase
  • NSD2 protein, human
  • NSD3 protein, human
  • FGFR1 protein, human
  • Receptor, Fibroblast Growth Factor, Type 1